First Time Loading...

Acumen Pharmaceuticals Inc
NASDAQ:ABOS

Watchlist Manager
Acumen Pharmaceuticals Inc Logo
Acumen Pharmaceuticals Inc
NASDAQ:ABOS
Watchlist
Price: 3.25 USD 0.93% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

ABOS Price Targets Summary
Acumen Pharmaceuticals Inc

Wall Street analysts forecast ABOS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABOS is 13.06 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

ABOS Lowest Forecast
Wall Street Target
10.1 USD
211% Upside
ABOS Average Forecast
Wall Street Target
13.06 USD
302% Upside
ABOS Highest Forecast
Wall Street Target
15.75 USD
385% Upside
Lowest
Price Target
10.1 USD
211% Upside
Average
Price Target
13.06 USD
302% Upside
Highest
Price Target
15.75 USD
385% Upside
Acumen Pharmaceuticals Inc Competitors:
Price Targets
9969
InnoCare Pharma Ltd
37% Upside
STOK
Stoke Therapeutics Inc
109% Upside
AFMD
Affimed NV
331% Upside
BIOA B
BioArctic AB
86% Upside
9969
InnoCare Pharma Ltd
37% Upside
STOK
Stoke Therapeutics Inc
109% Upside
AFMD
Affimed NV
331% Upside
BIOA B
BioArctic AB
86% Upside
ALERS
Eurobio Scientific SA
105% Upside
RCUS
Arcus Biosciences Inc
158% Upside
ICCC
ImmuCell Corp
180% Upside
OXB
Oxford BioMedica PLC
48% Upside

Revenue
Forecast

Revenue Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Acumen Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
ABOS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABOS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABOS stock valuation using valuation multiples.
Wall Street Estimates
ABOS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABOS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABOS's stock price target?
Price Target
13.06 USD

According to Wall Street analysts, the average 1-year price target for ABOS is 13.06 USD with a low forecast of 10.1 USD and a high forecast of 15.75 USD.

ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.